Southeast Life Sciences’ flagship event, AdvanSE, brings together the best the region’s life science ecosystem has to offer. That includes networking opportunities, PitchRounds and programming that educates and informs.
While a bit of ‘last mile’ fluidity remains, we invite you to check out the AdvanSE 2022 agenda, curated thoughtfully thanks to the hard work of our program committee. For early, late stage and strategic innovators, for investors, for solution providers and university representatives, there is something for everyone.
Presenters on the agenda include representatives from:
Avanos,
Silicon Valley Bank,
Keiretsu Forum,
The US FDA
HealthQuest Capital,
The Global Center for Medical Innovation,
Write2Market and many more industry leaders.
The 2022 class of PitchRounds presenting companies is strong. Check them out for yourself.
Topically, strategies and tactics for accelerating commercialization, key considerations and state of affairs in supply chain and manufacturing, successful ‘marriage’ stories shared by innovators and their investors, along with spotlights on women in life sciences and SE Color represent in part our best effort to ensure the quality of content delivers value for all attendees.
Check out the agenda and if you haven’t done so, there is still time to register for the one-stop-shop for life science innovation in the southeastern United States.
Still need convincing?
Fact: In the past 20 years, 501 PitchRounds at AdvanSE presenting companies have raised $7.2 billion, while 70 companies subsequently executed M&A and IPO events and counting.
In just 48 hours at AdvanSE, investors and partners can see the very best of what the southeast life sciences innovation ecosystem has to offer. The highly efficient “shopping” of the investors, corporate partners and companies that attend help the critical mass of innovators in the region further their ingenuity through partnerships and investment.
Still not convinced? Consider these.
Kayla Rodriguez, MBA – Co-founder & COO, SweetBio
FROM PITCHROUNDS VETERAN & SWEETBIO CO-FOUNDER & CEO KAYLA RODRIGUEZ GRAFF
“Three weeks before the 2015 conference, SweetBio wasn’t even incorporated. Six months later, Innova and MB Venture Partners co-led a significant seed round to support FDA 510(k) clearance of our honey-incorporated advanced wound care product. From that first conference, gaining insights and feedback from Randy Scott, David Huizenga, Chris Hooper, and others helped shape our company. From investor insights to introductions to industry advisors and fellow peers, this event has us coming back year after year.”
FROM INVESTOR KYP SIRINAKIS, CO-FOUNDER & MANAGING PARTNER, EPIDAREX CAPITAL
“By attending AdvanSE, I get to meet some of the leading entrepreneurs and interesting companies in the Southeast. AdvanSE offers exclusive opportunities to network with other investors and strategics and is the one-stop shop for innovation in the region.” Kyp Sirinakis, Co-Founder and Managing Partner, — Epidarex Capital
FROM PITCHROUNDS VETERAN & INNOVATOR VANCE CLEMENT, CEO, LINEUS MEDICAL
“This conference provided us an incredible opportunity to connect with a large number of diverse life science professionals, which is not always easy to do for life science companies headquartered in the heartland. The exposure to investors and collaborators was instrumental to our early stage company.” – Vance Clement, CEO, — Lineus Medical, Pitchrounds participant 2019 and 2021
FROM INVESTOR AND HEALTHQUEST CAPITAL VENTURE PARTNER TOM CALLAWAY
“HealthQuest partners are active participants in reviewing early stage businesses and investing across the healthcare spectrum – including medical devices, healthcare information technologies, diagnostics, novel delivery systems that improve patient outcomes and reduce costs. We find PitchRounds an early preview of companies that are rapidly growing and might become opportunities for investing as they seek growth capital.” – Tom Callaway, Venture Partner, — HealthQuest Capital